We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wells Fargo
WFC
$261B
| $118M | 0.57% |
2,127,847
-5,113
| -0.2% | -$290K |
|
|
AET
27
DELISTED
Aetna Inc
AET
| $114M | 0.55% |
895,537
+19,342
| +2% | +$2.43M |
|
28
UnitedHealth
UNH
$382B
| $114M | 0.55% |
696,311
+114,444
| +20% | +$18.7M |
|
29
eBay
EBAY
$48.5B
| $114M | 0.54% |
3,394,641
-251,975
| -7% | -$8.19M |
|
30
Sysco
SYY
$39.7B
| $114M | 0.54% |
2,193,816
+406,330
| +23% | +$21.5M |
|
31
Thermo Fisher Scientific
TMO
$210B
| $113M | 0.54% |
736,340
+23,280
| +3% | +$3.56M |
|
32
Illinois Tool Works
ITW
$81B
| $113M | 0.54% |
851,248
+4,289
| +0.5% | +$555K |
|
33
Tyson Foods
TSN
$20.2B
| $112M | 0.53% |
1,812,009
+105,848
| +6% | +$6.67M |
|
34
Alphabet (Google) Class C
GOOG
$3.9T
| $112M | 0.53% |
2,691,600
+27,560
| +1% | +$1.13M |
|
35
Pfizer
PFE
$140B
| $111M | 0.53% |
3,404,922
-55,847
| -2% | -$1.76M |
|
36
Trane Technologies
TT
$106B
| $109M | 0.52% |
1,335,560
+162,766
| +14% | +$12.9M |
|
37
Intel
INTC
$473B
| $103M | 0.49% |
2,853,708
-79,741
| -3% | -$2.89M |
|
38
Amphenol
APH
$188B
| $101M | 0.48% |
5,703,816
-150,356
| -3% | -$2.6M |
|
|
CELG
39
DELISTED
Celgene Corp
CELG
| $101M | 0.48% |
813,433
+365,300
| +82% | +$43.7M |
|
40
Honeywell
HON
$76.6B
| $101M | 0.48% |
891,985
+108,632
| +14% | +$12M |
|
|
ESRX
41
DELISTED
Express Scripts Holding Company
ESRX
| $98.6M | 0.47% |
1,496,122
+36,051
| +2% | +$2.48M |
|
42
Mastercard
MA
$474B
| $96.6M | 0.46% |
858,686
+241,732
| +39% | +$26.5M |
|
43
Visa
V
$674B
| $95.8M | 0.46% |
1,077,681
-121,210
| -10% | -$10.4M |
|
44
IBM
IBM
$203B
| $95.5M | 0.46% |
573,741
+101,890
| +22% | +$17.1M |
|
45
PNC Financial Services
PNC
$100B
| $95.4M | 0.46% |
793,216
-85,315
| -10% | -$10.4M |
|
|
DD
46
DELISTED
Du Pont De Nemours E I
DD
| $91.2M | 0.44% |
1,135,358
-7,569
| -0.7% | -$588K |
|
|
MRSH
47
Marsh
MRSH
$85.8B
| $90.7M | 0.43% |
1,227,195
-33,900
| -3% | -$2.42M |
|
48
Waters Corp
WAT
$36.7B
| $90.3M | 0.43% |
577,700
+26,626
| +5% | +$3.98M |
|
49
SLB Ltd
SLB
$78B
| $87.8M | 0.42% |
1,124,078
-274,779
| -20% | -$22.5M |
|
50
Applied Materials
AMAT
$426B
| $87.3M | 0.42% |
2,243,335
-141,155
| -6% | -$5.07M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.